Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CONCORD BIOTECH vs ANUH PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CONCORD BIOTECH ANUH PHARMA CONCORD BIOTECH/
ANUH PHARMA
 
P/E (TTM) x 63.9 16.3 393.1% View Chart
P/BV x 13.8 3.3 417.6% View Chart
Dividend Yield % 0.4 1.3 33.4%  

Financials

 CONCORD BIOTECH   ANUH PHARMA
EQUITY SHARE DATA
    CONCORD BIOTECH
Mar-24
ANUH PHARMA
Mar-24
CONCORD BIOTECH/
ANUH PHARMA
5-Yr Chart
Click to enlarge
High Rs1,608260 619.3%   
Low Rs90080 1,124.0%   
Sales per share (Unadj.) Rs97.2129.1 75.3%  
Earnings per share (Unadj.) Rs29.412.0 245.7%  
Cash flow per share (Unadj.) Rs34.613.7 252.4%  
Dividends per share (Unadj.) Rs8.752.50 350.0%  
Avg Dividend yield %0.71.5 47.4%  
Book value per share (Unadj.) Rs145.958.1 251.1%  
Shares outstanding (eoy) m104.6250.11 208.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x12.91.3 980.5%   
Avg P/E ratio x42.614.2 300.4%  
P/CF ratio (eoy) x36.312.4 292.5%  
Price / Book Value ratio x8.62.9 294.0%  
Dividend payout %29.720.9 142.4%   
Avg Mkt Cap Rs m131,1998,513 1,541.1%   
No. of employees `000NANA-   
Total wages/salary Rs m1,230194 634.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m10,1696,470 157.2%  
Other income Rs m338121 279.2%   
Total revenues Rs m10,5076,591 159.4%   
Gross profit Rs m4,356758 575.0%  
Depreciation Rs m53686 624.3%   
Interest Rs m3210 332.7%   
Profit before tax Rs m4,126783 526.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,045183 572.3%   
Profit after tax Rs m3,081601 513.0%  
Gross profit margin %42.811.7 365.8%  
Effective tax rate %25.323.3 108.6%   
Net profit margin %30.39.3 326.4%  
BALANCE SHEET DATA
Current assets Rs m8,9623,362 266.6%   
Current liabilities Rs m1,4221,527 93.1%   
Net working cap to sales %74.228.4 261.4%  
Current ratio x6.32.2 286.3%  
Inventory Days Days9465 145.0%  
Debtors Days Days1,2551,072 117.1%  
Net fixed assets Rs m8,0451,091 737.7%   
Share capital Rs m105251 41.8%   
"Free" reserves Rs m15,1622,662 569.6%   
Net worth Rs m15,2662,912 524.2%   
Long term debt Rs m00-   
Total assets Rs m17,0074,453 382.0%  
Interest coverage x130.682.8 157.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.61.5 41.1%   
Return on assets %18.313.7 133.6%  
Return on equity %20.220.6 97.9%  
Return on capital %27.227.2 100.1%  
Exports to sales %45.957.5 79.9%   
Imports to sales %12.660.3 20.9%   
Exports (fob) Rs m4,6703,719 125.5%   
Imports (cif) Rs m1,2793,900 32.8%   
Fx inflow Rs m4,6703,719 125.5%   
Fx outflow Rs m1,2793,900 32.8%   
Net fx Rs m3,390-181 -1,873.1%   
CASH FLOW
From Operations Rs m2,655129 2,053.9%  
From Investments Rs m-1,5469 -16,841.9%  
From Financial Activity Rs m-992-86 1,158.0%  
Net Cashflow Rs m11653 220.7%  

Share Holding

Indian Promoters % 44.1 69.9 63.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 17.9 0.0 89,600.0%  
FIIs % 8.1 0.0 40,500.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 55.9 30.1 185.9%  
Shareholders   84,298 23,910 352.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CONCORD BIOTECH With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on CONCORD BIOTECH vs ANUH PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

CONCORD BIOTECH vs ANUH PHARMA Share Price Performance

Period CONCORD BIOTECH ANUH PHARMA S&P BSE HEALTHCARE
1-Day 0.99% 1.08% 0.93%
1-Month 9.09% -1.11% -0.54%
1-Year 59.03% 13.35% 43.19%
3-Year CAGR 28.71% 22.57% 20.23%
5-Year CAGR 16.35% 23.93% 26.17%

* Compound Annual Growth Rate

Here are more details on the CONCORD BIOTECH share price and the ANUH PHARMA share price.

Moving on to shareholding structures...

The promoters of CONCORD BIOTECH hold a 44.1% stake in the company. In case of ANUH PHARMA the stake stands at 69.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of CONCORD BIOTECH and the shareholding pattern of ANUH PHARMA.

Finally, a word on dividends...

In the most recent financial year, CONCORD BIOTECH paid a dividend of Rs 8.8 per share. This amounted to a Dividend Payout ratio of 29.7%.

ANUH PHARMA paid Rs 2.5, and its dividend payout ratio stood at 20.9%.

You may visit here to review the dividend history of CONCORD BIOTECH, and the dividend history of ANUH PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5% Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5%(10:30 am)

Asian markets traded higher on Friday, following the overnight rally on Wall Street, and the release of economic data in the region.